Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
The CBF Study
NCT01468285Phase 4Completed
- Sponsor
- Abbott Laboratories
- Start
- Feb 2012
- Primary completion
- Apr 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of betahistine in gait disorder, balance disorder, sponsored by Abbott Laboratories. Started Feb 2012; status: completed.
02
Drugs
betahistine
03
Conditions
gait disorderbalance disorder
Beyond the preview
Go deeper on NCT01468285.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01468285.